Potential of adenovirus and baculovirus vectors for the delivery of shRNA against morbilliviruses

Antiviral Research

Volumn 90, Issue 1, 2011, Pages 98-101

  Nizamani, Zaheer Ahmed ^a   Keil, Gunther M ^b   Albina, Emmanuel ^a   Holz, Carine ^a   Minet, Cécile ^a   Kwiatek, Olivier ^a   Libeau, Geneviève ^a   Servan de Almeida, Renata ^a  

^a CIRAD   (France)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Adenovirus; Baculovirus; Morbillivirus; PPRV; RNAi

Indexed keywords

ADENOVIRUS VECTOR; BACULOVIRUS VECTOR; NUCLEOPROTEIN; SHORT HAIRPIN RNA;

ADENOVIRUS; ARTICLE; BACULOVIRUS; HUMAN; IN VITRO STUDY; MORBILLIVIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; BACULOVIRIDAE; BIOLOGICAL PRODUCTS; CERCOPITHECUS AETHIOPS; GENETIC VECTORS; PESTE-DES-PETITS-RUMINANTS VIRUS; RNA, SMALL INTERFERING; VERO CELLS; VIRAL LOAD; VIRAL PROTEINS; VIRUS REPLICATION;

ADENOVIRIDAE; MAMMALIA; MORBILLIVIRUS; PESTE-DES-PETITS-RUMINANTS VIRUS;

EID: 79953692372     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.02.007     Document Type: Article

References (28)

1. Aagaard L., Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv. Drug Deliv. Rev. 2007, 59:75-86.
2. Andersson M., Warolen M., Nilsson J., Selander M., Sterky C., Bergdahl K., Sorving C., James S.R., Doverskog M. Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cells. BMC Cell Biol. 2007, 8:6.
3. Brun A., Albina E., Barret T., Chapman D.A., Czub M., Dixon L.K., Keil G.M., Klonjkowski B., Le Potier M.F., Libeau G., Ortego J., Richardson J., Takamatsu H.H. Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems. Vaccine 2008, 26:6508-6528.
4. Feng Z., Jiang P., Wang X., Li Y., Jiang W. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo. Antivir. Res. 2008, 77:186-194.
5. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
6. Hofmann C., Strauss M. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 1998, 5:531-536.
7. Kaname Y., Tani H., Kataoka C., Shiokawa M., Taguwa S., Abe T., Moriishi K., Kinoshita T., Matsuura Y. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J. Virol. 2010, 84:3210-3219.
8. Keil G.M., Klopfleisch C., Giesow K., Blohm U. Novel vectors for simultaneous high-level dual protein expression in vertebrate and insect cells by recombinant baculoviruses. J. Virol. Methods 2009, 160:132-137.
9. Keita D., Servan de Almeida R., Libeau G., Albina E. Identification and mapping of a region on the mRNA of Morbillivirus nucleoprotein susceptible to RNA interference. Antivir. Res. 2008, 80:158-167.
10. Kim S.M., Lee K.N., Park J.Y., Ko Y.J., Joo Y.S., Kim H.S., Park J.H. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo. Antivir. Res. 2008, 80:178-184.
11. Kost T.A., Condreay J.P. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20 2002, 4:173-180.
12. Li G., Jiang P., Li Y., Wang X., Huang J., Du Y., Zeshan B. Effective suppression of replication of porcine reproductive and respiratory syndrome virus by adenovirus-mediated small interfering RNAs targeting ORF1b, 5 and 7 genes. J. Virol. Methods 2009, 157:40-46.
13. Li S., Tseng W.C., Stolz D.B., Wu S.P., Watkins S.C., Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. 1999, 6:585-594.
14. Lu L., Ho Y., Kwang J. Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem. Biophys. Res. Commun. 2006, 340:1178-1183.
15. Otaki M., Jiang D.P., Sasayama M., Nagano-Fujii M., Hotta H. Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus. Microbiol. Immunol. 2007, 51:985-991.
16. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 1938, 27:493-497.
17. Sakamoto N., Tanabe Y., Yokota T., Satoh K., Sekine-Osajima Y., Nakagawa M., Itsui Y., Tasaka M., Sakurai Y., Cheng-Hsin C., Yano M., Ohkoshi S., Aoyagi Y., Maekawa S., Enomoto N., Kohara M., Watanabe M. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA. J. Gastroenterol. Hepatol. 2008, 23:1437-1447.
18. Sarkis C., Serguera C., Petres S., Buchet D., Ridet J.L., Edelman L., Mallet J. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:14638-14643.
19. Servan de Almeida R., Keita D., Libeau G., Albina E. Control of ruminant morbillivirus replication by small interfering RNA. J. Gen. Virol. 2007, 88:2307-2311.
20. Starkey J.L., Chiari E.F., Isom H.C. Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro. J. Gen. Virol. 2009, 90:115-126.
21. Suzuki H., Saitoh H., Suzuki T., Takaku H. Inhibition of influenza virus by baculovirus-mediated shRNA. Nucl. Acids Symp. Ser. (Oxf.) 2009, 287-288.
22. Suzuki H., Tamai N., Shimotohno K., Matsuura Y., Takaku H. Suppression of HCV RNA replication by baculovirus-mediated shRNA expression vectors. Antivir. Res. 2008, 78. A49-A49.
23. Uprichard S.L., Boyd B., Althage A., Chisari F.V. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:773-778.
24. van Loo N.D., Fortunati E., Ehlert E., Rabelink M., Grosveld F., Scholte B.J. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J. Virol. 2001, 75:961-970.
25. Volkman L.E., Goldsmith P.A. In Vitro Survey of Autographa californica Nuclear Polyhedrosis Virus Interaction with Nontarget Vertebrate Host Cells. Appl Environ Microbiol. 45 1983, 3:1085-1093.
26. Volpers C., Kochanek S. Adenoviral vectors for gene transfer and therapy. J. Gene Med. 2004, 6(Suppl. 1):S164-171.
27. Yang Y., Lo S.L., Yang J., Goh S.S., Wu C., Feng S.S., Wang S. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 2009, 30:5767-5774.
28. Zhang H., Kolb F.A., Jaskiewicz L., Westhof E., Filipowicz W. Single processing center models for human Dicer and bacterial RNase III. Cell 2004, 118:57-68.